We are live on
!
Find out more
CG Oncology
CGON
CGON
195 hedge funds and large institutions have $3.43B invested in CG Oncology in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 72 increasing their positions, 50 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
151% more call options, than puts
Call options by funds: $74M | Put options by funds: $29.6M
115% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 20
44% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 50
11% more funds holding
Funds holding: 176 → 195 (+19)
10% more capital invested
Capital invested by funds: $3.13B → $3.43B (+$303M)
8% more funds holding in top 10
Funds holding in top 10: 12 → 13 (+1)
0.6% more ownership
Funds ownership: 101.84% → 102.44% (+0.6%)
Holders
195
Holders Change
+19
Holders Change %
+10.8%
% of All Funds
2.37%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.16%
New
43
Increased
72
Reduced
50
Closed
20
Calls
$74M
Puts
$29.6M
Net Calls
+$44.5M
Net Calls Change
+$37.9M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$76.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$39.3M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$31.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$20.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$18.3M |
